# NEJM published first CTX001 CRISPR patient cases for sickle cell and β-thalassemia

Date: 2020

_No public text on this fact yet._

## Drivers

- Gene-Editing Diffusion: https://factrail.ai/drivers/gene-editing-diffusion

## Sources

_Sources are listed on the canonical page._

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/frangoul-nejm-ctx001-sickle-thalassemia-december-2020